Company Profile
We are passionate about providing phage-based solutions to achieve your scientific goals.
Cell Origins provides researchers with critical phage-based laboratory services and kits. We focus upon the use of filamentous phage as an inexpensive, reliable, highly stable, and effective replacement for many products currently in the market. We are currently developing a product for identification and phenotypic characterization of commonly used cell lines. Additionally, we provide phage display services including consulting, ligand selections, and construction of libraries.
Management
Leann Qi, Co-Founder, CEO
Jessica Newton-Northup, Co-Founder, COO
Mette Soendergaard, Co-Founder, CSO
Our Origins
Cell Origins LLC was founded by Mette Soendergaard (Ph.D.), Jessica Newton Northup (M.S.), and Leann Kuhlmann Qi (M.B.A) in 2019.
Years earlier, Dr. Mette Soendergaard and Jessica Newton Northup formed and maintained a collaborative relationship while at the University of Missouri, the birthplace of phage display technology. Here, they developed a passion for phage display technology and development of phage-based methods that they now bring to Cell Origins LLC.
The passion of our team for phage-based solutions brought us to address the growing challenge identified by the National Institute of Health; that is the need for a product to verify the identity and phenotype of cell lines. Thus, we are currently developing a phage-based product for identification and phenotypic characterization of commonly used cell lines.
Business Summary
Cell Origins LLC was formed to address a growing challenge identified by the National Institutes of Health and cited within the scientific literature of the need for a product to verify the health of cell lines. In vitro data collected from cell cultures is often problematic due to contamination, genetic drift, and/or inappropriate growth conditions. Cell Origins LLC is also developing dual-display phage to replace antibodies in protein isolation experiments to provide the research community with a more cost-effective and stable solution.